Suppr超能文献

下咽癌患者的生存分析:一项基于医院癌症登记处的研究。

A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.

作者信息

Krishnatreya Manigreeva, Kataki Amal Chandra, Sharma Jagannath Dev, Baishya Nizara, Rahman Tashnin, Bhattcharyya Mouchumee, Das Ashok Kumar, Kalita Manoj

机构信息

1Department of Cancer Epidemiology and Biostatistics, Dr B. Borooah Cancer Institute, Guwahati, India.

2Patterns of Care and Survival Project, Dr B. Borooah Cancer Institute, Guwahati, India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2019 Oct;71(Suppl 1):798-804. doi: 10.1007/s12070-018-1556-4. Epub 2018 Dec 27.

Abstract

To study the survival in patients affected with hypopharyngeal cancer among treatment groups and different stages. Data of hypopharyngeal cancer patients diagnosed from 1st January 2010 to 31st December 2010 was used in the present study. The cases were analyzed for gender, age group distribution, sub-sites at presentation, stage at diagnosis and the type of treatments. Survival from the date of first diagnosis was estimated and hazard ratios were calculated. Survival probability and hazards ratios (HR) were calculated by Kaplan-Meier method and Cox-proportional regression analysis respectively. Censoring of patient who survived longer than 5 years was done. Active follow-up was done for the survival analysis. The study cohort included 217 patients and treatment compliance was observed in 46.9% of cases. The median age at diagnosis was 57 years (range 24-90), 86.2% of cases were locally advanced cases (stage III and IV), pyriform sinus was major sub-site (96%), radiotherapy was main treatment modality alone in 84.8% of cases, median survival was 31 months and 5-year overall survival was 36.9%, and HR for stage IV was 1.9 ( = 0.03, 95% CI - 1.04 to 3.7). In developing setting of North East India, radiotherapy was the main modality of treatment for hypopharyngeal cancer patients, and understanding the clinical parameters and survival of this group of cancers is crucial for its control.

摘要

研究下咽癌患者在不同治疗组和不同分期中的生存率。本研究使用了2010年1月1日至2010年12月31日诊断的下咽癌患者数据。对病例进行了性别、年龄组分布、就诊时的亚部位、诊断分期和治疗类型分析。估计从首次诊断日期起的生存率并计算风险比。生存概率和风险比(HR)分别通过Kaplan-Meier法和Cox比例回归分析计算。对存活超过5年的患者进行删失处理。为进行生存分析进行了主动随访。研究队列包括217例患者,46.9%的病例观察到治疗依从性。诊断时的中位年龄为57岁(范围24 - 90岁),86.2%的病例为局部晚期病例(III期和IV期),梨状窝是主要亚部位(96%),84.8%的病例单独以放疗作为主要治疗方式,中位生存期为31个月,5年总生存率为36.9%,IV期的HR为1.9(P = 0.03,95%CI - 1.04至3.7)。在印度东北部的发展中地区,放疗是下咽癌患者的主要治疗方式了解这组癌症的临床参数和生存率对其控制至关重要。

相似文献

1
A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.
Indian J Otolaryngol Head Neck Surg. 2019 Oct;71(Suppl 1):798-804. doi: 10.1007/s12070-018-1556-4. Epub 2018 Dec 27.
2
A survival study of uterine cervical patients in the North East India: Hospital-cancer registry-based analysis.
J Cancer Res Ther. 2018 Jul-Sep;14(5):1089-1093. doi: 10.4103/0973-1482.184516.
5
[Clinical characteristics of 97 hypopharyngeal carcinoma cases].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Mar;29(6):542-6.
6
[Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jul;49(7):533-8.
9
[The clinical characteristics and treatment outcomes of 386 patients with hypopharyngeal cancer].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Jun 7;51(6):433-9. doi: 10.3760/cma.j.issn.1673-0860.2016.06.007.
10
[Outcome of hypopharyngeal cancer].
Nihon Jibiinkoka Gakkai Kaiho. 1996 Sep;99(9):1185-9. doi: 10.3950/jibiinkoka.99.1185.

引用本文的文献

1
High Risk Human Papillomavirus Prevalence in Patients with Hypopharynx Cancer of Northeast India: A Pilot Study.
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4381-4385. doi: 10.1007/s12070-024-04866-7. Epub 2024 Jul 16.
2
Clinical Conundrum: Unveiling a Unique Presentation of Hypopharyngeal Carcinoma.
Cureus. 2024 Apr 6;16(4):e57727. doi: 10.7759/cureus.57727. eCollection 2024 Apr.
3
High Pretreatment LDH Predicts Poor Prognosis in Hypopharyngeal Cancer.
Front Oncol. 2021 Mar 11;11:641682. doi: 10.3389/fonc.2021.641682. eCollection 2021.

本文引用的文献

1
Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Otolaryngol Head Neck Surg. 2018 Apr;158(4):677-684. doi: 10.1177/0194599817746391. Epub 2017 Dec 19.
2
Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands.
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):181-189. doi: 10.1007/s00405-017-4766-6. Epub 2017 Oct 28.
3
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
Lancet Oncol. 2017 Sep;18(9):1221-1237. doi: 10.1016/S1470-2045(17)30458-8. Epub 2017 Jul 27.
5
Survival in Head and Neck Cancers - Results of A Multi- Institution Study.
Asian Pac J Cancer Prev. 2016;17(4):1745-54. doi: 10.7314/apjcp.2016.17.4.1745.
6
Randomized Clinical Trials and Observational Studies: Is There a Battle?
J Clin Oncol. 2016 Mar 10;34(8):772-3. doi: 10.1200/JCO.2015.64.7487. Epub 2016 Jan 19.
7
Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer.
Ann Surg Oncol. 2016 Jun;23(6):2054-61. doi: 10.1245/s10434-016-5088-4. Epub 2016 Jan 19.
8
[Clinical characteristics of 97 hypopharyngeal carcinoma cases].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Mar;29(6):542-6.
9
Living with the Elekta Compact: Limitations and ways around them.
J Cancer Res Ther. 2015 Apr-Jun;11(2):479-81. doi: 10.4103/0973-1482.139605.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验